The FDA has changed the labeling on ECT, and Vaughn McCall clarifies where this treatment fits among newer interventions like ketamine and TMS.

Learn how an understanding of patient’s temperament and the meaning of their life story can unlock psychotherapeutic avenues of treatment on our interview with Margaret Chisolm.

Margaret Chisolm shares the Perspectives model, a way of assessing patients that builds on the DSM takes the famous manual a few steps further.

Depression and cognitive impairment on benzos, tardive dyskinesia, anticholinergics, and neurotoxicity from high dose stimulants. These are the side effects that patients aren’t likely to notice until it’s too late.

Allen Frances helped create DSM-IV, but in this episode he takes on its diagnostic overreach.

Stimulants may hold the prize for effect size in ADHD, but nonstimulants have advantages for the right patient. Nicholas Nissen shows us how to use five medications, two supplements, and lifestyle approaches in ADHD.